Baystate Wing Hospital in Palmer, Mass., has contacted an unknown number of patients who may have been exposed to hepatitis or HIV due to a potential sterilization issue during surgeries performed ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
A patient told MassLive she was horrified to receive a phone call from her surgeon post-operation saying she should be tested for bloodborne pathogens.
19h
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Providing feedback following point-of-care urine testing for tenofovir concentrations was associated with increased PrEP ...
A new study in Australia found that treating male partners can reduce BV reinfections, suggesting that BV may be sexually ...
Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...
Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback